SLC18A2 and Parkinson disease: Predominant dysregulation of dopamine metabolism pathways here was also reported in several studies [49–51], specifically related genes, such as Slc6a3, Slc18a2, and Ddc. It should be noted that some differences are existing in molecular-level between MPTP/p-induced PD model and PD patients.